Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 0.7x - 0.8x | 0.8x |
| Historical Pb Multiple | 0.2x - 4.7x | 0.9x |
| Fair Value | €3.10 - €3.42 | €3.26 |
| Upside | 28.0% - 41.5% | 34.7% |
| Benchmarks | - | Full Ticker |
| Simply Better Brands Corp. | - | OTCPK:SBBC.F |
| Tilray Brands, Inc. | - | NasdaqGS:TLRY |
| CannaPharmaRX, Inc. | - | OTCPK:CPMD |
| InnoCan Pharma Corporation | - | OTCPK:INNP.F |
| IntelGenx Technologies Corp. | - | OTCPK:IGXT |
| InMed Pharmaceuticals Inc. | - | DB:MWG |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| SBBC.F | TLRY | CPMD | INNP.F | IGXT | MWG | |||
| OTCPK:SBBC.F | NasdaqGS:TLRY | OTCPK:CPMD | OTCPK:INNP.F | OTCPK:IGXT | DB:MWG | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | -115.6% | 82.6% | 118.4% | 48.2% | -0.9% | -24.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -24.2% | -83.6% | -7587.8% | -11453.7% | -1021.6% | -1029.1% | ||
| Prior Fiscal Year | -18.9% | -231.6% | NA | -147.1% | -1125.3% | -192.2% | ||
| Latest Fiscal Year | -30.4% | -31.1% | NA | -34.4% | -955.4% | -166.9% | ||
| Latest Twelve Months | -26.0% | -30.0% | 408.3% | -9.0% | -1049.5% | -163.8% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -195.0% | -17.0% | -1371.2% | -383.1% | -1051.4% | -104.9% | ||
| Prior Fiscal Year | -196.1% | -37.7% | NM | -48.7% | -552.3% | -75.1% | ||
| Latest Twelve Months | -277.1% | -7.3% | NM | -55.1% | NM | -83.5% | ||
| Next Fiscal Year | -0.6% | 3.8% | #NUM! | #NUM! | -1073.4% | -280.6% | ||
| Two Fiscal Years Forward | -5098.4% | 5.3% | #NUM! | 561.3% | 123.9% | 250.6% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.8x | 0.7x | 7.8x | 1.3x | 27.8x | 0.7x | ||
| Price / LTM EPS | -3.3x | -2.5x | 1.9x | -14.8x | -2.6x | -0.4x | ||
| Price / Book | 11.7x | 0.2x | -0.2x | 7.5x | -1.9x | 0.5x | ||
| Price / Fwd Book | -19.6x | 0.2x | -0.2x | 8.4x | 3.5x | -2.3x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -1.9x | 0.2x | 11.7x | |||||
| Historical P/B Ratio | 0.2x | 0.9x | 4.7x | |||||
| Selected P/B Multiple | 0.7x | 0.8x | 0.8x | |||||
| (x) Book Value | 6 | 6 | 6 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | SBBC.F | TLRY | CPMD | INNP.F | IGXT | MWG | |
| Value of Common Equity | 71 | 621 | 3 | 34 | 29 | 4 | |
| (/) Shares Outstanding | 107.2 | 937.7 | 656.3 | 260.4 | 174.7 | 1.4 | |
| Implied Stock Price | 0.66 | 0.66 | 0.00 | 0.13 | 0.17 | 2.62 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.08 | |
| Implied Stock Price (Trading Cur) | 0.66 | 0.66 | 0.00 | 0.13 | 0.17 | 2.42 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.08 | |